CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade First Wave BioPharma, Inc. - FWBI CFD

0.7659
1.71%
0.0301
Low: 0.7356
High: 0.7921
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0301
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.753
Open* 0.7895
1-Year Change* 2.53%
Day's Range* 0.7356 - 0.7356
52 wk Range 0.1345-7.05
Average Volume (10 days) N/A
Average Volume (3 months) 69.4665
Market Cap 6.70436
P/E Ratio N/A
Shares Outstanding 41590300
Revenue N/A
EPS -4.87481
Dividend (Yield %) N/A
Beta 1.72651
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 29, 2022 0.7659 -0.0274 -3.45% 0.7933 0.8094 0.7122
Nov 28, 2022 0.7530 0.1122 17.51% 0.6408 0.7698 0.6408
Nov 25, 2022 0.6541 0.0131 2.04% 0.6410 0.6607 0.6310
Nov 23, 2022 0.6511 0.0079 1.23% 0.6432 0.6729 0.6210
Nov 22, 2022 0.6440 -0.0886 -12.09% 0.7326 0.7466 0.6116
Nov 21, 2022 0.6509 -0.0495 -7.07% 0.7004 0.7005 0.6243
Nov 18, 2022 0.7501 -0.1089 -12.68% 0.8590 0.8590 0.7400
Nov 17, 2022 0.8550 -0.0010 -0.12% 0.8560 0.8591 0.8490
Nov 16, 2022 0.8571 -0.0221 -2.51% 0.8792 0.8792 0.8401
Nov 15, 2022 0.8695 0.0105 1.22% 0.8590 0.8888 0.8489
Nov 14, 2022 0.8595 0.0099 1.17% 0.8496 0.8839 0.8392
Nov 11, 2022 0.8691 0.0092 1.07% 0.8599 0.8899 0.8390
Nov 10, 2022 0.8590 -0.0098 -1.13% 0.8688 0.8918 0.8391
Nov 9, 2022 0.8596 -0.0033 -0.38% 0.8629 0.8987 0.8392
Nov 8, 2022 0.9167 -0.0712 -7.21% 0.9879 0.9879 0.9105
Nov 7, 2022 0.9780 -0.0395 -3.88% 1.0175 1.0374 0.9381
Nov 4, 2022 0.9780 0.0596 6.49% 0.9184 1.0275 0.9084
Nov 3, 2022 0.9232 0.0049 0.53% 0.9183 0.9482 0.8886
Nov 2, 2022 0.9358 -0.0025 -0.27% 0.9383 0.9582 0.8490
Nov 1, 2022 0.9384 -0.1090 -10.41% 1.0474 1.0474 0.9185

First Wave BioPharma, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 0 0 0 0
Total Operating Expense 6.32516 10.2212 13.4318 14.7437 26.8313 59.0569
Selling/General/Admin. Expenses, Total 3.43886 6.93171 8.17431 6.04227 7.27976 18.3696
Research & Development 2.49611 2.39548 4.98555 7.85849 19.105 38.3204
Depreciation / Amortization 0.6902 0.754 0.06191 0.84299 0.048 0.015
Other Operating Expenses, Total -0.3 0.14 0.21 0
Operating Income -6.32516 -10.2212 -13.4318 -14.7437 -26.8313 -59.0569
Interest Income (Expense), Net Non-Operating -5.93749 -0.8752 -0.10185 -0.43394 -5.84013 -0.01007
Other, Net -2.32902 0 0.5291
Net Income Before Taxes -14.5917 -11.0964 -13.5336 -15.1777 -32.6715 -58.5378
Net Income After Taxes -14.5917 -11.0964 -13.5336 -15.1777 -32.6715 -58.5378
Net Income Before Extra. Items -14.5917 -11.0964 -13.5336 -15.1777 -32.6715 -58.5378
Net Income -14.5917 -11.0964 -13.5336 -15.1777 -32.6715 -58.5378
Income Available to Common Excl. Extra. Items -14.5917 -11.0964 -13.5336 -15.1777 -41.7323 -84.5186
Income Available to Common Incl. Extra. Items -14.5917 -11.0964 -13.5336 -15.1777 -41.7323 -84.5186
Diluted Net Income -14.5917 -11.0964 -13.5336 -15.1777 -41.7323 -84.5186
Diluted Weighted Average Shares 0.65048 1.06288 1.54393 2.24256 2.84363 8.92573
Diluted EPS Excluding Extraordinary Items -22.4322 -10.4399 -8.76569 -6.76803 -14.6757 -9.4691
Diluted Normalized EPS -22.4322 -10.4399 -8.76569 -6.76803 -14.5356 -9.20559
Revenue 0
Unusual Expense (Income) 0.39857 2.35199
Total Adjustments to Net Income -9.06087 -25.9807
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Total Operating Expense 8.21354 9.27689 30.3995 11.167 9.38207
Selling/General/Admin. Expenses, Total 5.69751 3.62809 6.02116 3.03678 4.40556
Research & Development 2.51503 5.6468 24.3783 5.77821 4.97652
Depreciation / Amortization 0.001 0.002
Operating Income -8.21354 -9.27689 -30.3995 -11.167 -9.38207
Interest Income (Expense), Net Non-Operating -0.00474 -0.00295 -0.00074 -0.00123 -0.00547
Other, Net 0.53265 0.0009 -0.00057 -0.00428 -0.2393
Net Income Before Taxes -7.68563 -9.27894 -30.4008 -11.1725 -9.62684
Net Income After Taxes -7.68563 -9.27894 -30.4008 -11.1725 -9.62684
Net Income Before Extra. Items -7.68563 -9.27894 -30.4008 -11.1725 -9.62684
Net Income -7.68563 -9.27894 -30.4008 -11.1725 -9.62684
Total Adjustments to Net Income -22.2956 -3.45087 -0.11809 -0.11623 -0.68577
Income Available to Common Excl. Extra. Items -29.9812 -12.7298 -30.5189 -11.2887 -10.3126
Income Available to Common Incl. Extra. Items -29.9812 -12.7298 -30.5189 -11.2887 -10.3126
Diluted Net Income -29.9812 -12.7298 -30.5189 -11.2887 -10.3126
Diluted Weighted Average Shares 5.53481 7.81244 9.34236 12.9223 15.5447
Diluted EPS Excluding Extraordinary Items -5.41684 -1.62943 -3.26672 -0.87359 -0.66342
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -5.41684 -1.62943 -3.26672 -0.69158 -0.66342
Unusual Expense (Income) 2.35199
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 2.96397 1.95257 4.8 3.40829 7.86978 9.42495
Cash and Short Term Investments 1.77353 0.57347 1.11434 0.1758 6.06214 8.24868
Cash 1.77353 0.57347 1.11434 0.1758 6.06214 8.24868
Short Term Investments 0
Total Receivables, Net 0.96104 1.10413 3.17268 2.6373 0.55149 0
Prepaid Expenses 0.22941 0.27496 0.51298 0.59519 1.25615 1.17627
Total Assets 6.75384 5.47967 7.4694 8.90288 12.9239 11.79
Property/Plant/Equipment, Total - Net 0.15162 0.13399 0.12885 0.15978 0.09257 0.40931
Goodwill, Net 1.76755 2.01624 1.92483 1.88669 2.05405 1.91171
Intangibles, Net 1.83602 1.34596 0.57048 3.40708 2.87954 0
Other Long Term Assets, Total 0.03468 0.03092 0.04523 0.04105 0.02792 0.04401
Total Current Liabilities 2.34084 2.47908 2.99552 4.28564 15.5454 12.3004
Payable/Accrued 2.17846 2.05534 0.6701 0.53343 0
Accrued Expenses 0.00719 0.00719 0.53829 0.15441 0.18443 0.49706
Notes Payable/Short Term Debt 0.15519 0.41655 0.25503 1.5213 0.55241 0.64124
Other Current Liabilities, Total 0 0.39299 13.25 8.48018
Total Liabilities 3.54084 3.81908 2.99552 4.28564 15.5646 19.6115
Total Long Term Debt 0 0 0 0 0 0
Other Liabilities, Total 1.2 1.34 0 0 0.01912 7.31114
Total Equity 3.213 1.66059 4.47387 4.61724 -2.64069 -7.82155
Common Stock 0.00096 0.00121 0.00177 0.00268 0.00312 0.00149
Additional Paid-In Capital 27.561 37.6696 53.1393 68.5759 93.8349 147.305
Retained Earnings (Accumulated Deficit) -22.8871 -33.9834 -47.5171 -62.6947 -95.3662 -153.904
Other Equity, Total -1.46188 -2.02679 -1.15011 -1.26656 -1.11255 -1.22414
Total Liabilities & Shareholders’ Equity 6.75384 5.47967 7.4694 8.90288 12.9239 11.79
Total Common Shares Outstanding 0.96311 1.20426 1.77049 2.68005 3.11503 14.8559
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Property/Plant/Equipment, Total - Gross 0.33225 0.4233 0.13097 0.42402
Accumulated Depreciation, Total -0.20339 -0.26352 -0.0384 -0.01471
Accounts Payable 1.53211 1.68351 1.55859 2.68191
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 13.1704 8.61528 7.50249 9.42495 6.55017
Cash and Short Term Investments 12.0256 8.07449 7.21065 8.24868 5.69499
Cash 12.0256 8.07449 7.21065 8.24868 5.69499
Total Receivables, Net 0.50166 0 0 0 0.02806
Prepaid Expenses 0.64313 0.54079 0.29184 1.17627 0.82713
Total Assets 17.9829 13.7768 12.424 11.79 8.82544
Property/Plant/Equipment, Total - Net 0.06162 0.48488 0.44889 0.40931 0.3788
Property/Plant/Equipment, Total - Gross 0.0812 0.4861 0.45632 0.42402 0.40083
Accumulated Depreciation, Total -0.01958 -0.00123 -0.00743 -0.01471 -0.02203
Goodwill, Net 1.97396 1.99129 1.94474 1.91171 1.86207
Intangibles, Net 2.74765 2.61576 2.48388 0
Other Long Term Assets, Total 0.02924 0.0696 0.04403 0.04401 0.0344
Total Current Liabilities 3.57464 6.45412 19.0983 12.3004 14.2157
Accounts Payable 1.44072 4.44991 18.4478 2.68191 3.44993
Accrued Expenses 0.32383 0.31246 0.22987 0.49706 0.7883
Notes Payable/Short Term Debt 0.34708 0.13957 0 0.64124 0.40277
Other Current Liabilities, Total 1.46302 1.55218 0.42063 8.48018 9.57473
Total Liabilities 3.58121 6.73988 19.394 19.6115 18.0652
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.00657 0.28575 0.29569 7.31114 3.8495
Total Equity 14.4017 7.03692 -6.96999 -7.82155 -9.23979
Common Stock 0.00749 0.00826 0.00111 0.00149 0.00215
Additional Paid-In Capital 118.693 120.585 137.028 147.305 155.571
Retained Earnings (Accumulated Deficit) -103.052 -112.331 -142.732 -153.904 -163.531
Other Equity, Total -1.24734 -1.2255 -1.26711 -1.22414 -1.28254
Total Liabilities & Shareholders’ Equity 17.9829 13.7768 12.424 11.79 8.82544
Total Common Shares Outstanding 7.49269 8.25851 11.1152 14.8559 21.5488
Preferred Stock - Non Redeemable, Net 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -14.5917 -11.0964 -13.5336 -15.1777 -32.6715 -58.5378
Cash From Operating Activities -4.53486 -7.18464 -10.8693 -14.0335 -11.2215 -32.2882
Cash From Operating Activities 0.04431 0.04952 0.06191 0.0631 0.0378 0.01471
Amortization 0.6902 0.70448 0.73654 0.95695 0.52755 0.52755
Non-Cash Items 8.61743 3.42595 3.57765 1.82513 6.73365 8.60641
Changes in Working Capital 0.70487 -0.26821 -1.7118 -1.70099 14.1509 17.101
Cash From Investing Activities -0.01236 -0.03217 -0.30547 -0.0241 0.08735 -10.3195
Capital Expenditures -0.01236 -0.03217 -0.30547 -0.0241 -0.00417 -0.06949
Cash From Financing Activities 5.74629 6.01322 11.7121 13.145 17.0461 44.7635
Financing Cash Flow Items -1.42011 0
Issuance (Retirement) of Stock, Net 5.28 5.00923 11.9028 9.53834 14.1861 44.6747
Issuance (Retirement) of Debt, Net 1.8864 1.00399 -0.19068 3.60664 2.86003 0.08883
Foreign Exchange Effects -0.00722 0.00353 0.00354 -0.02593 -0.02559 0.03076
Net Change in Cash 1.19186 -1.20005 0.54087 -0.93855 5.88635 2.18654
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0.00415 0.00401 0.00803 0.10546 0
Other Investing Cash Flow Items, Total 0.09152 -10.25
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -7.68563 -16.9646 -47.3654 -58.5378 -9.62684
Cash From Operating Activities -5.07339 -10.6961 -26.4254 -32.2882 -7.91207
Cash From Operating Activities 0.00102 0.00301 0.00939 0.01471 0.00732
Amortization 0.13189 0.26377 0.39566 0.52755 0
Non-Cash Items 1.80638 1.7359 2.04186 8.60641 0.36042
Cash Interest Paid 0.00514 0 0 0 0
Changes in Working Capital 0.67294 4.26576 18.493 17.101 1.34703
Cash From Investing Activities 0 -9.07393 -10.3215 -10.3195
Capital Expenditures 0 -0.07393 -0.07145 -0.06949
Cash From Financing Activities 11.0506 21.8326 37.9406 44.7635 5.36715
Financing Cash Flow Items -9.53235 -2.41496
Issuance (Retirement) of Stock, Net 20.7883 22.2454 38.493 44.6747 8.02057
Issuance (Retirement) of Debt, Net -0.20532 -0.41284 -0.55241 0.08883 -0.23847
Foreign Exchange Effects -0.01374 -0.05019 -0.04525 0.03076 -0.00877
Net Change in Cash 5.96349 2.01235 1.1485 2.18654 -2.5537
Cash Taxes Paid 0 0 0
Other Investing Cash Flow Items, Total -9 -10.25 -10.25

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

First Wave BioPharma, Inc. Company profile

About First Wave BioPharma Inc

First Wave BioPharma, Inc., formerly AzurRx BioPharma, Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. It is focused on advancing a therapeutic development pipeline built around its two technologies: niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. The Company's niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis (UP) and ulcerative proctosigmoiditis; and FW-ICI-AC, for Grade 1 and Grade 2 immune checkpoint inhibitor-associated colitis and diarrhea in advanced oncology patients. It is also advancing FW-EPI (adrulipase) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis.

Financial summary

BRIEF: For the nine months ended 30 September 2021, First Wave BioPharma Inc revenues was not reported. Net loss applicable to common stockholders increased from $23.4M to $73.2M. Higher net loss reflects Research and development expenses - Bala increase of 85% to $8.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$8.35 to -$10.31.

Industry: Biotechnology & Medical Research (NEC)

777 Yamato Road
Suite 502
33431

Income Statement

People also watch

BTC/USD

16,910.25 Price
+4.180% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 66.00

XRP/USD

0.40 Price
+3.700% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00328

Oil - Crude

79.09 Price
+3.280% 1D Chg, %
Long position overnight fee -0.0108%
Short position overnight fee -0.0029%
Overnight fee time 22:00 (UTC)
Spread 0.03

US100

11,515.90 Price
-0.770% 1D Chg, %
Long position overnight fee -0.0167%
Short position overnight fee 0.0059%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading